80 results
Page 3 of 4
8-K
EX-10.1
im1vhnqysvxi rravd0
4 Aug 20
Qualigen Therapeutics, Inc. Announces Closing of $10 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
4:25pm
8-K
EX-10.2
l58v 3r4q3c8dt
4 Aug 20
Qualigen Therapeutics, Inc. Announces Closing of $10 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
4:25pm
424B5
bb3 brir7uqqm
4 Aug 20
Prospectus supplement for primary offering
6:16am
8-K
EX-10.1
g2gnja24 jyoi800tddp
10 Jul 20
Qualigen Therapeutics, Inc. Announces Closing of $8 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
4:40pm
424B5
h32nqq ylrodegssinm9
10 Jul 20
Prospectus supplement for primary offering
2:35pm
8-K
EX-10.4
ws4hxu825 2glck44sa
9 Jul 20
Qualigen Therapeutics, Inc. Announces $8 Million
6:02am
8-K
EX-10.1
p8ck re6m5kcfu7ch1
9 Jul 20
Qualigen Therapeutics, Inc. Announces $8 Million
6:02am
8-K
EX-10.2
m307j8rvtwvmheznmi
29 May 20
Qualigen Therapeutics Announces Merger Closing
5:03pm
8-K
EX-10.20
gg3jigcizivy6thlg
29 May 20
Qualigen Therapeutics Announces Merger Closing
5:03pm
8-K
EX-10.3
ih7ubv28 3gh7
29 May 20
Qualigen Therapeutics Announces Merger Closing
5:03pm
8-K
EX-10.1
toveuhfr nc2rrki
29 May 20
Qualigen Therapeutics Announces Merger Closing
5:03pm
8-K
EX-10.11
a0n9jd1ggmm
29 May 20
Qualigen Therapeutics Announces Merger Closing
5:03pm
424B3
dusdpz5wqxjbldsr
9 Apr 20
Prospectus supplement
9:30am
S-4/A
nzu tlh7l8kqnk0grx
13 Mar 20
Registration of securities issued in business combination transactions (amended)
5:28pm
S-4/A
EX-10.54
208gho9kqgnaanr
13 Mar 20
Registration of securities issued in business combination transactions (amended)
5:28pm